-transparent.png){kind=logo}
Horary plasmatic dosages of Dopa and metabolites in 30 treated parkinsonian patients have shown that, within the group of patients treated with L-Dopa combined with an extracerebral decarboxylase inhibitor, highly significant by increased plasmatic O-methyl-dopa levels can be found in patients with dyskinesias compared with those without dyskinesias. On the contrary, in these two subgroups of patients, plasmatic Dopa levels are not significantly different. By comparing some favoured Dopa and O-methyl-dopa levels between these two subgroups of patients, it seems more likely, that the elevated plasmatic O-methyl-dopa levels are due to an progressive accumulation on of its compound than to an excessive formation from Dopa.
J Perret, and
C Feuerstein, and
J Pellat, and
F Serre, and
M Gavend, and
M Tanche
September 2012,
The European journal of neuroscience,
J Perret, and
C Feuerstein, and
J Pellat, and
F Serre, and
M Gavend, and
M Tanche
November 2020,
Brain sciences,
J Perret, and
C Feuerstein, and
J Pellat, and
F Serre, and
M Gavend, and
M Tanche
March 1998,
Brain : a journal of neurology,
J Perret, and
C Feuerstein, and
J Pellat, and
F Serre, and
M Gavend, and
M Tanche
January 2013,
Journal of Parkinson's disease,
J Perret, and
C Feuerstein, and
J Pellat, and
F Serre, and
M Gavend, and
M Tanche
October 2013,
Biochemical pharmacology,
J Perret, and
C Feuerstein, and
J Pellat, and
F Serre, and
M Gavend, and
M Tanche
February 2014,
The Journal of neuroscience : the official journal of the Society for Neuroscience,
J Perret, and
C Feuerstein, and
J Pellat, and
F Serre, and
M Gavend, and
M Tanche
August 2015,
Brain research,
J Perret, and
C Feuerstein, and
J Pellat, and
F Serre, and
M Gavend, and
M Tanche
January 2002,
Revue neurologique,
J Perret, and
C Feuerstein, and
J Pellat, and
F Serre, and
M Gavend, and
M Tanche
January 2011,
Proceedings of the National Academy of Sciences of the United States of America,
J Perret, and
C Feuerstein, and
J Pellat, and
F Serre, and
M Gavend, and
M Tanche
January 1998,
Therapie,
